Regulatory circuitry governing fungal development, drug resistance, and disease.
Open accessThe DOI matches its Crossref record; 662 of the 662 references it cites were found in a registry or an index.
Abstract
SUMMARY: Pathogenic fungi have become a leading cause of human mortality due to the increasing frequency of fungal infections in immunocompromised populations and the limited armamentarium of clinically useful antifungal drugs. Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus are the leading causes of opportunistic fungal infections. In these diverse pathogenic fungi, complex signal transduction cascades are critical for sensing environmental changes and mediating appropriate cellular responses. For C. albicans , several environmental cues regulate a morphogenetic switch from yeast to filamentous growth, a reversible transition important for virulence. Many of the signaling cascades regulating morphogenesis are also required for cells to adapt and survive the cellular stresses imposed by antifungal drugs. Many of these signaling networks are conserved in C. neoformans and A. fumigatus , which undergo distinct morphogenetic programs during specific phases of their life cycles. Furthermore, the key mechanisms of fungal drug resistance, including alterations of the drug target, overexpression of drug efflux transporters, and alteration of cellular stress responses, are conserved between these species. This review focuses on the circuitry regulating fungal morphogenesis and drug resistance and the impact of these pathways on virulence. Although the three human-pathogenic fungi highlighted in this review are those most frequently encountered in the clinic, they represent a minute fraction of fungal diversity. Exploration of the conservation and divergence of core signal transduction pathways across C. albicans , C. neoformans , and A. fumigatus provides a foundation for the study of a broader diversity of pathogenic fungi and a platform for the development of new therapeutic strategies for fungal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 1,3-β-D-glucan synthases are encoded by FKS1, FKS2, and FKS3 in S. cerevisiae, C. glabrata, and C. albicans, and require a regulatory subunit encoded by RHO1 for activity [3], [20], [32], [33].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mechanisms of acquired resistance mostly fall into two classes (Figure 1B): (i) mutations leading to increased expression of the target or the alteration of its binding affinity towards the drug; and (ii) mutations leading to reduced intracellular accumulation of the drug by means of increasing the activity or expression of drug efflux pumps or, conversely, reducing the import of the drug [69].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, resistant strains with no known resistance-conferring mutations in target genes have also been reported [6,69], implying the presence of yet undiscovered mechanisms.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition by azoles commonly leads to depletion of ergosterol and accumulation of other sterols, such as lanosterol, eburicol and the toxic 14α-methyl-3,6-diol, within fungal cell membranes (Watson et al., 1989; Shapiro et al., 2011; Chen et al., 2016).”
From Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles (2018) · cites this paper as Shapiro et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of antifungal drugs in the clinic targeting the biosynthesis of ergosterol inhibit the activities of ERG enzymes and direct the biosynthesis of the ergosterol pathway to an alternative route”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [40]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 662
Stathopoulos-Gerontides, A., Guo, J. J., & Cyert, M. S. (1999) · Genes & Development · doi:10.1101/gad.13.7.798 · Cited by 240
Morphogenesis in Candida Albicans
Odds, F. C., & Kerridge, D. (1985) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418509104425 · Cited by 240
Morphogenesis and cell cycle progression in Candida albicans
Berman, J. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.10.007 · Cited by 237 · cited 3×
“The buds become elongated after a prolonged G2 phase compared to yeast (50).”
BackgroundInfluentialDunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhäuser, J., & Rogers, P. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00103-08 · Cited by 236
Effect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234 · cited 1×
“Morphogenesis is a critical part of biofilm formation (34, 60, 486), and biofilms are generally more resistant to antifungal drugs than are free-moving planktonic cells (34, 475, 479).”
BackgroundBahn, Y.-S., Kojima, K., Cox, G. M., & Heitman, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-02-0113 · Cited by 234
Mortensen, K. L., Mellado, E., Lass-Flörl, C., Rodriguez-Tudela, J. L., Johansen, H. K., & Arendrup, M. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00692-10 · Cited by 233
Schweizer, A., Rupp, S., Taylor, B. N., Röllinghoff, M., & Schröppel, K. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02132.x · Cited by 232
Lipid Raft Polarization Contributes to Hyphal Growth in Candida albicans
Martin, S. W., & Konopka, J. B. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.675-684.2004 · Cited by 232
APSES Proteins Regulate Morphogenesis and Metabolism in Candida albicans
Doedt, T. (2004) · Molecular Biology of the Cell · doi:10.1091/10.1091/mbc.e03-11-0782 · Cited by 232
Matthews, R. C., Rigg, G., Hodgetts, S., Carter, T., Chapman, C., Gregory, C., Illidge, C., & Burnie, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2208-2216.2003 · Cited by 231
Seidler, M. J., Salvenmoser, S., & Müller, F.-M. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-08 · Cited by 229 · cited 1×
“fumigatus adheres to and develops biofilms on polystyrene, human bronchial epithelial cells, and, especially, bronchial epithelial cells of cystic fibrosis patients (517).”
BackgroundSynergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms
Uppuluri, P., Nett, J., Heitman, J., & Andes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-07 · Cited by 228
RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans
Alspaugh, J. A., Cavallo, L. M., Perfect, J. R., & Heitman, J. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01852.x · Cited by 226
Balashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225
Bicanic, T., Harrison, T., Niepieklo, A., Dyakopu, N., & Meintjes, G. (2006) · Clinical Infectious Diseases · doi:10.1086/507895 · Cited by 224
Interactions of Candida albicans with epithelial cells
Zhu, W., & Filler, S. G. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01412.x · Cited by 223
Lass-Florl, C., Kofler, G., Kropshofer, G., Hermans, J., Kreczy, A., Dierich, M. P., & Niederwieser, D. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.497 · Cited by 223
Lessing, F., Kniemeyer, O., Wozniok, I., Loeffler, J., Kurzai, O., Haertl, A., & Brakhage, A. A. (2007) · Eukaryotic Cell · doi:10.1128/ec.00267-07 · Cited by 221
Lane, S., Birse, C., Zhou, S., Matson, R., & Liu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104484200 · Cited by 220
Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway
Fu, Y., Ibrahim, A. S., Sheppard, D. C., Chen, Y., French, S. W., Cutler, J. E., Filler, S. G., & Edwards, J. E. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02873.x · Cited by 218 · cited 1×
“Specific examples include the expression of genes encoding secreted aspartic proteases (178, 409) as well the adhesins HWP1 and ALS3 (193, 550, 573, 651).”
BackgroundCell growth control: little eukaryotes make big contributions
De Virgilio, C., & Loewith, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209884 · Cited by 218
Kraus, P. R., Fox, D. S., Cox, G. M., & Heitman, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03508.x · Cited by 217 · cited 3×
“neoformans, the MAPK Mpk1 is activated by phosphorylation in response to caspofungin as well as the chitin synthase inhibitor nikkomycin Z (285).”
BackgroundInfluentialHomothallic and heterothallic mating in the opportunistic pathogen Candida albicans
Alby, K., Schaefer, D., & Bennett, R. J. (2009) · Nature · doi:10.1038/nature08252 · Cited by 217
Iridovirus and Microsporidian Linked to Honey Bee Colony Decline
Bromenshenk, J. J., Henderson, C. B., Wick, C. H., Stanford, M. F., Zulich, A. W., Jabbour, R. E., Deshpande, S. V., McCubbin, P. E., Seccomb, R. A., Welch, P. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013181 · Cited by 217
James, T. Y., Litvintseva, A. P., Vilgalys, R., Morgan, J. A. T., Taylor, J. W., Fisher, M. C., Berger, L., Weldon, C., du Preez, L., & Longcore, J. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000458 · Cited by 217
Role of Candida albicans Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism
Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216 · cited 1×
“The transcription factor Upc2 upregulates ERG11 expression in response to azoles and thereby contributes to azole resistance (534).”
BackgroundMircescu, M. M., Lipuma, L., van Rooijen, N., Pamer, E. G., & Hohl, T. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/600380 · Cited by 216 · cited 2×
“This was not the case for mice depleted of alveolar macrophages or depleted of neutrophils at later time points (384).”
ResultCarlisle, P. L., Banerjee, M., Lazzell, A., Monteagudo, C., López-Ribot, J. L., & Kadosh, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804061106 · Cited by 215
The SAGA continues: expanding the cellular role of a transcriptional co-activator complex
Baker, S. P., & Grant, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210603 · Cited by 214
Ji, H., Zhang, W., Zhou, Y., Zhang, M., Zhu, J., Song, Y., Lü, J., & Zhu, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990589g · Cited by 213
Chang, Y. C., Bien, C. M., Lee, H., Espenshade, P. J., & Kwon‐Chung, K. J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05676.x · Cited by 212 · cited 2×
“Furthermore, SRE1 functions under low-oxygen conditions as a transcriptional activator of numerous genes involved in ergosterol biosynthesis and the transport of iron, copper, and other molecules (96).”
BackgroundCandida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210
Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210
Mühlschlegel, F. A., & Fonzi, W. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5960 · Cited by 209 · cited 2×
“These genes were identified in genetic screens and encode pH-regulated glucosidases, which maintain the cell wall shape and structure (182, 398, 510).”
BackgroundA contact-activated kinase signals Candida albicans invasive growth and biofilm development
Kumamoto, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407097102 · Cited by 209
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
Murad, A. M. A., D'Enfert, C., Gaillardin, C., Tournu, H., Tekaia, F., Talibi, D., Marechal, D., Marchais, V., Cottin, J., & Brown, A. J. P. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02713.x · Cited by 208
Evolution of Drug Resistance in Experimental Populations of Candida albicans
Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., & Kohn, L. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1515-1522.2000 · Cited by 207
Self-citationThe Flo8 Transcription Factor Is Essential for Hyphal Development and Virulence in Candida albicans
Cao, F., Lane, S., Raniga, P. P., Lu, Y., Zhou, Z., Ramon, K., Chen, J., & Liu, H. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0502 · Cited by 207
Cramer, R. A., Gamcsik, M. P., Brooking, R. M., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Balibar, C. J., Graybill, J. R., Perfect, J. R., Abraham, S. N., et al. (2006) · Eukaryotic Cell · doi:10.1128/ec.00049-06 · Cited by 207
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
Zhang, Y.-Q., Gamarra, S., Garcia-Effron, G., Park, S., Perlin, D. S., & Rao, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000939 · Cited by 206 · cited 1×
“ATPases, thereby disrupting cation homeostasis within the cell and providing a mechanistic insight into the cellular consequences of ergosterol depletion (647).”
BackgroundSnelders, E., Karawajczyk, A., Schaftenaar, G., Verweij, P. E., & Melchers, W. J. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01599-09 · Cited by 206
Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2163-2167.2005 · Cited by 205
Gcn4 co-ordinates morphogenetic and metabolic responses to amino acid starvation in Candida albicans
Tripathi, G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf507 · Cited by 204
A Single-Transformation Gene Function Test in Diploid Candida albicans
Enloe, B., Diamond, A., & Mitchell, A. P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.20.5730-5736.2000 · Cited by 204
Multi-azole resistance in Aspergillus fumigatus
Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 203
Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202 · cited 1×
“An analysis of atrF mRNA from susceptible isolates and from the earliest-identified itraconazole-resistant isolates revealed that resistance correlated with increased levels of atrF (539).”
BackgroundCryptococcal Interactions with the Host Immune System
Voelz, K., & May, R. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00039-10 · Cited by 202
Maidan, M. M., De Rop, L., Serneels, J., Exler, S., Rupp, S., Tournu, H., Thevelein, J. M., & Van Dijck, P. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-09-0780 · Cited by 201
Functional characterization of the Cdc42p binding domain of yeast Ste20p protein kinase
Leberer, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.83 · Cited by 200
Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro
Martinez, L. R., & Casadevall, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1021-1033.2006 · Cited by 199
Interaction of Cryptococcus neoformans Rim101 and Protein Kinase A Regulates Capsule
O'Meara, T. R., Norton, D., Price, M. S., Hay, C., Clements, M. F., Nichols, C. B., & Alspaugh, J. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000776 · Cited by 198
Adaptation to environmental pH in Candida albicans and its relation to pathogenesis
Davis, D. (2003) · Current Genetics · doi:10.1007/s00294-003-0415-2 · Cited by 196
Candida morphogenesis and host–pathogen interactions
Whiteway, M., & Oberholzer, U. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.06.005 · Cited by 196
Thompson, J. R., Douglas, C. M., Li, W., Jue, C. K., Pramanik, B., Yuan, X., Rude, T. H., Toffaletti, D. L., Perfect, J. R., & Kurtz, M. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.2.444-453.1999 · Cited by 196
Diamond, R. D., & Clark, R. A. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.487-495.1982 · Cited by 194
Fonzi, W. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.22.7070-7079.1999 · Cited by 193 · cited 1×
“These genes were identified in genetic screens and encode pH-regulated glucosidases, which maintain the cell wall shape and structure (182, 398, 510).”
BackgroundKübler, E., Mösch, H.-U., Rupp, S., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20321 · Cited by 193
Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p
Leberer, E., Ziegelbauer, K., Schmidt, A., Harcus, D., Dignard, D., Ash, J., Johnson, L., & Thomas, D. Y. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00252-1 · Cited by 193
Reinoso-Martín, C., Schüller, C., Schuetzer-Muehlbauer, M., & Kuchler, K. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1200-1210.2003 · Cited by 193
Bockmühl, D. P., Krishnamurthy, S., Gerads, M., Sonneborn, A., & Ernst, J. F. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02688.x · Cited by 193
Byrnes III, E. J., Bildfell, R. J., Frank, S. A., Mitchell, T. G., Marr, K. A., & Heitman, J. (2009) · The Journal of Infectious Diseases · doi:10.1086/597306 · Cited by 193
Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193 · cited 2×
“In the presence of caspofungin, (1,3)- -D-glucan and (1,6)- -D-glucan levels decreased by 81% and 73%, respectively (562).”
BackgroundLaverdière, M., Lalonde, R. G., Baril, J.-G., Sheppard, D. C., Park, S., & Perlin, D. S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl022 · Cited by 192
Mann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 189
The innate immune response to Aspergillus fumigatus
Balloy, V., & Chignard, M. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.07.002 · Cited by 188
Tetracycline-Inducible Gene Expression and Gene Deletion in Candida albicans
Park, Y.-N., & Morschhäuser, J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.8.1328-1342.2005 · Cited by 188
Streptococcus mutans Competence-Stimulating Peptide Inhibits Candida albicans Hypha Formation
Jarosz, L. M., Deng, D. M., van der Mei, H. C., Crielaard, W., & Krom, B. P. (2009) · Eukaryotic Cell · doi:10.1128/ec.00070-09 · Cited by 187
Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans
Sonneborn, A., Bockmühl, D. P., Gerads, M., Kurpanek, K., Sanglard, D., & Ernst, J. F. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01705.x · Cited by 187
Septin Function in Candida albicans Morphogenesis
Warenda, A. J., & Konopka, J. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0013 · Cited by 186
MAP kinase pathways as regulators of fungal virulence
Román, E., Arana, D. M., Nombela, C., Alonso‐Monge, R., & Plá, J. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.02.001 · Cited by 185
Richie, D. L., Hartl, L., Aimanianda, V., Winters, M. S., Fuller, K. K., Miley, M. D., White, S., McCarthy, J. W., Latgé, J.-P., Feldmesser, M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000258 · Cited by 185
Biswas, K., & Morschhäuser, J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04576.x · Cited by 185
Xue, C., Bahn, Y.-S., Cox, G. M., & Heitman, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0699 · Cited by 185
The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans
Steenbergen, J. N., & Casadevall, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00092-3 · Cited by 183
Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood
Kitchen, L. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.241 · Cited by 183
Micheli, M. D., Bille, J., Schueller, C., & Sanglard, D. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02814.x · Cited by 182
Setiadi, E. R., Doedt, T., Cottier, F., Noffz, C., & Ernst, J. F. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.040 · Cited by 182
Chun, C. D., Liu, O. W., & Madhani, H. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030022 · Cited by 181 · cited 1×
“Unusual phenotypes have been observed for tco1 mutants, as strains showed increased melanin biosynthesis but attenuated virulence (28, 103).”
BackgroundSelf-Regulation of Candida albicans Population Size during GI Colonization
White, S. J., Rosenbach, A., Lephart, P., Nguyen, D., Benjamin, A., Tzipori, S., Whiteway, M., Mecsas, J., & Kumamoto, C. A. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030184 · Cited by 181
Pukkila-Worley, R., Gerrald, Q. D., Kraus, P. R., Boily, M.-J., Davis, M. J., Giles, S. S., Cox, G. M., Heitman, J., & Alspaugh, J. A. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.1.190-201.2005 · Cited by 181
Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179
Maligie, M. A., & Selitrennikoff, C. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2851-2856.2005 · Cited by 178
Distinct Roles for Dectin-1 and TLR4 in the Pathogenesis of Aspergillus fumigatus Keratitis
Leal, S. M., Cowden, S., Hsia, Y.-C., Ghannoum, M. A., Momany, M., & Pearlman, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000976 · Cited by 177
Immunosuppression in vitro by a metabolite of a human pathogenic fungus.
Müllbacher, A., & Eichner, R. D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3835 · Cited by 177
Pagano, L., Girmenia, C., Mele, L., Ricci, P., Tosti, M. E., Nosari, A., Buelli, M., Picardi, M., Allione, B., Corvatta, L., et al. (2001) · PubMed · Cited by 176
Valiante, V., Heinekamp, T., Jain, R., Härtl, A., & Brakhage, A. A. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.09.006 · Cited by 176
Master and Commander in Fungal Pathogens: the Two-Component System and the HOG Signaling Pathway
Bahn, Y.-S. (2008) · Eukaryotic Cell · doi:10.1128/ec.00323-08 · Cited by 176
The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence
Kelly, M. T., MacCallum, D. M., Clancy, S. D., Odds, F. C., Brown, A. J. P., & Butler, G. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04185.x · Cited by 175
Bonnett, C. R., Cornish, E. J., Harmsen, A. G., & Burritt, J. B. (2006) · Infection and Immunity · doi:10.1128/iai.00909-06 · Cited by 174 · cited 1×
“fumigatus conidia in the lungs in a murine model of infection (67).”
BackgroundRamon, A. M., Porta, A., & Fonzi, W. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.24.7524-7530.1999 · Cited by 174
Román, E., Nombela, C., & Pla, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10611-10627.2005 · Cited by 173
Cramer, R. A., Perfect, B. Z., Pinchai, N., Park, S., Perlin, D. S., Asfaw, Y. G., Heitman, J., Perfect, J. R., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00086-08 · Cited by 172
Görlach, J., Fox, D. S., Cutler, N. S., Cox, G. M., Perfect, J. R., & Heitman, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.14.3618 · Cited by 171
The G-Protein β Subunit GPB1 Is Required for Mating and Haploid Fruiting in Cryptococcus neoformans
Wang, P., Perfect, J. R., & Heitman, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.352-362.2000 · Cited by 170
Bockmühl, D. P., & Ernst, J. F. (2001) · Genetics · doi:10.1093/genetics/157.4.1523 · Cited by 170
Del Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.739-746.2000 · Cited by 169 · cited 2×
“Specifically, the combined use of these agents results in a 30-fold reduction in the MIC of FK506 and a 4-fold reduction in the MIC of fluconazole (140).”
BackgroundSharkey, L. L., McNemar, M. D., Saporito-Irwin, S. M., Sypherd, P. S., & Fonzi, W. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5273-5279.1999 · Cited by 168
Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA
Soriani, F. M., Malavazi, I., Da Silva Ferreira, M. E., Savoldi, M., Von Zeska Kress, M. R., De Souza Goldman, M. H., Loss, O., Bignell, E., & Goldman, G. H. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06122.x · Cited by 168
Thermotolerance and virulence of Aspergillus fumigatus: role of the fungal nucleolus
Bhabhra, R., & Askew, D. S. (2005) · Medical Mycology · doi:10.1080/13693780400029486 · Cited by 168
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168
Liebmann, B., Müller, M., Braun, A., & Brakhage, A. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5193-5203.2004 · Cited by 168
Prill, S. K. ‐., Klinkert, B., Timpel, C., Gale, C. A., Schröppel, K., & Ernst, J. F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04401.x · Cited by 167
Kadosh, D., & Johnson, A. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2496-2505.2001 · Cited by 166
Eisman, B., Alonso-Monge, R., Román, E., Arana, D., Nombela, C., & Pla, J. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.2.347-358.2006 · Cited by 163
Mouyna, I., Morelle, W., Vai, M., Monod, M., Léchenne, B., Fontaine, T., Beauvais, A., Sarfati, J., Prévost, M., Henry, C., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04654.x · Cited by 163
Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1382-1383.2004 · Cited by 162 · cited 1×
“Although the echinocandins have been used in the clinic for only a relatively short time, cases of resistant isolates from patients treated with this antifungal have been documented (37, 224, 309, 447).”
BackgroundSudbery, P. E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02459.x · Cited by 161
Fortwendel, J. R., Juvvadi, P. R., Pinchai, N., Perfect, B. Z., Alspaugh, J. A., Perfect, J. R., & Steinbach, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01154-08 · Cited by 161 · cited 4×
“Intriguingly, while wild-type cells compensate for caspofungin-induced (1,3)- -D-glucan depletion by increasing chitin synthase gene expression and cell wall chitin contents, the cnaA and crzA deletion strains fail to do so (185, 186), indicating that calcineurin may regulate compensatory chitin synthesis in the prese…”
BackgroundInfluentialCO2 sensing in fungi and beyond
Bahn, Y.-S., & Mühlschlegel, F. A. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.09.003 · Cited by 160
Fu, Y., Rieg, G., Fonzi, W. A., Belanger, P. H., Edwards, J. E., & Filler, S. G. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1783-1786.1998 · Cited by 159 · cited 1×
“For instance, the expression of Als1 allows binding to epithelial cells (194), while the expression of the Als3 and Hwp1 proteins allows binding to fibrinogen and the salivary pellicle, and the expression of Eap1 proteins allows binding to polystyrene surfaces (420).”
BackgroundGenetic Architecture of Hsp90-Dependent Drug Resistance
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159 · cited 4×
“albicans and that the inhibition of Hsp90 blocks this activation (536), consistent with calcineurin being a key mediator of Hsp90-dependent azole resistance (113, 115).”
BackgroundInfluentialSelf-citationBahn, Y.-S., & Sundstrom, P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.3211-3223.2001 · Cited by 158
Steenbergen, J. N., Nosanchuk, J. D., Malliaris, S. D., & Casadevall, A. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.4862-4872.2003 · Cited by 157
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy
Wurtele, H., Tsao, S., Lépine, G., Mullick, A., Tremblay, J., Drogaris, P., Lee, E.-H., Thibault, P., Verreault, A., & Raymond, M. (2010) · Nature Medicine · doi:10.1038/nm.2175 · Cited by 157
White–opaque switching in Candida albicans
Lohse, M. B., & Johnson, A. D. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.09.010 · Cited by 156
Candida albicans Biofilm-Defective Mutants
Richard, M. L., Nobile, C. J., Bruno, V. M., & Mitchell, A. P. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.8.1493-1502.2005 · Cited by 155
The Protein Kinase Tor1 Regulates Adhesin Gene Expression in Candida albicans
Bastidas, R. J., Heitman, J., & Cardenas, M. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000294 · Cited by 154
Fortwendel, J. R., Juvvadi, P. R., Perfect, B. Z., Rogg, L. E., Perfect, J. R., & Steinbach, W. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00854-09 · Cited by 153 · cited 1×
“Intriguingly, while wild-type cells compensate for caspofungin-induced (1,3)- -D-glucan depletion by increasing chitin synthase gene expression and cell wall chitin contents, the cnaA and crzA deletion strains fail to do so (185, 186), indicating that calcineurin may regulate compensatory chitin synthesis in the prese…”
BackgroundTuch, B. B., Mitrovich, Q. M., Homann, O. R., Hernday, A. D., Monighetti, C. K., De La Vega, F. M., & Johnson, A. D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001070 · Cited by 153
Transcription Profiling of Cyclic AMP Signaling in Candida albicans
Harcus, D., Nantel, A., Marcil, A., Rigby, T., & Whiteway, M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0144 · Cited by 153
Evolution of Drug Resistance in Candida Albicans
Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151 · cited 2×
“The major limitation is that population dynamics cannot easily be monitored or controlled, such that there can be quiescent reservoirs of the pathogens, infection with multiple genotypes, and variable selection pressure across anatomical sites and over time; furthermore, parameters such as mutation rate, recombination…”
BackgroundSelf-citationNobile, C. J., Solis, N., Myers, C. L., Fay, A. J., Deneault, J.-S., Nantel, A., Mitchell, A. P., & Filler, S. G. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01198.x · Cited by 150 · cited 2×
“albicans (424) as well as defects in melanization in C.”
BackgroundCruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150 · cited 2×
“Furthermore, the pharmacological or genetic inhibition of this phosphatase renders cells unable to mate, since it is required for elongation and survival of the dikaryon (125).”
BackgroundResistance to fluconazole and amphotericin in Candida albicans from AIDS patients
Kelly, S. L., Lamb, D. C., Kelly, D. E., Loeffler, J., & Einsele, H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65949-1 · Cited by 149
Infection-related gene expression in Candida albicans
Brown, A. J. P., Odds, F. C., & Gow, N. A. R. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.04.001 · Cited by 148
da Silva Ferreira, M. E., Capellaro, J. L., dos Reis Marques, E., Malavazi, I., Perlin, D., Park, S., Anderson, J. B., Colombo, A. L., Arthington-Skaggs, B. A., Goldman, M. H. S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4405-4413.2004 · Cited by 147
Smith, W. L., & Edlind, T. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3532-3539.2002 · Cited by 147 · cited 9×
“The molecular basis for this increase in resistance was due to the overexpression of the drug pumps CDR1 and CDR2 in the cka2 mutant (78).”
InfluentialOdds, F. C., Van Gerven, F., Espinel-Ingroff, A., Bartlett, M. S., Ghannoum, M. A., Lancaster, M. V., Pfaller, M. A., Rex, J. H., Rinaldi, M. G., & Walsh, T. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.282 · Cited by 147
Lee, I., Oh, J.-H., Keats Shwab, E., Dagenais, T. R. T., Andes, D., & Keller, N. P. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.007 · Cited by 147
Enjalbert, B., & Whiteway, M. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.7.1203-1210.2005 · Cited by 145 · cited 1×
“albicans itself, represses hyphal growth and biofilm formation in dense populations (232, 478) and inhibits the expression of filament-specific transcripts (168).”
BackgroundMolecular Principles of Fungal Pathogenesis
(2006) · ASM Press eBooks · doi:10.1128/9781555815776 · Cited by 143
Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143
Lin, X., Jackson, J. C., Feretzaki, M., Xue, C., & Heitman, J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000953 · Cited by 143
Cryptococcus neoformans STE12α Regulates Virulence but Is Not Essential for Mating
Chang, Y. C., Wickes, B. L., Miller, G. F., Penoyer, L. A., & Kwon-Chung, K. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.871 · Cited by 143
Pfaller, M. A., Messer, S. A., Georgopapadakou, N., Martell, L. A., Besterman, J. M., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00618-09 · Cited by 143
The Spitzenkörper: a molecular perspective
Virag, A., & Harris, S. D. (2005) · Mycological Research · doi:10.1016/j.mycres.2005.09.005 · Cited by 142
Heilmann, C. J., Schneider, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-09 · Cited by 142 · cited 1×
“Furthermore, G648D and G643A point mutations in Upc2 cause a hyperactivation of the transcription factor, resulting in the overexpression of ergosterol biosynthesis genes and increased fluconazole resistance (164, 223).”
BackgroundA Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatus
Rocha, E. M. F., Garcia-Effron, G., Park, S., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00917-07 · Cited by 141
Johnston, S. A., & May, R. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001041 · Cited by 141
Thewes, S., Kretschmar, M., Park, H., Schaller, M., Filler, S. G., & Hube, B. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05614.x · Cited by 140
Population genomics of drug resistance in Candida albicans
Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., & Anderson, J. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102291099 · Cited by 140 · cited 1×
“albicans have shown that the mechanisms of resistance arising in experimental populations are also found in clinical isolates that evolved resistance in a human host (116).”
BackgroundSelf-citationLiebmann, B., Gattung, S., Jahn, B., & Brakhage, A. A. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-003-0852-0 · Cited by 139
Heteroresistance to Fluconazole and Voriconazole in Cryptococcus neoformans
Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I., & Kwon-Chung, K. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1856 · Cited by 139
Nielsen, K., Cox, G. M., Litvintseva, A. P., Mylonakis, E., Malliaris, S. D., Benjamin, D. K., Giles, S. S., Mitchell, T. G., Casadevall, A., Perfect, J. R., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4922-4933.2005 · Cited by 139
Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3653-3656.2003 · Cited by 139 · cited 19×
“In many fungal species, they enter the fungal cell by facilitated diffusion (363) and act through an unhindered nitrogen atom in the azole ring, which binds to an iron atom in the heme group located in the active site of Erg11 (623).”
BackgroundInfluentialGood fungi gone bad: The corruption of calcineurin
Fox, D. S., & Heitman, J. (2002) · BioEssays · doi:10.1002/bies.10157 · Cited by 137
Latgé, J. P., Mouyna, I., Tekaia, F., Beauvais, A., Debeaupuis, J. P., & Nierman, W. (2005) · Medical Mycology · doi:10.1080/13693780400029155 · Cited by 137
Potential Basis for Amphotericin B Resistance in Aspergillus terreus
Blum, G., Perkhofer, S., Haas, H., Schrettl, M., Würzner, R., Dierich, M. P., & Lass-Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01280-07 · Cited by 137
Enhanced Production of Farnesol by Candida albicans Treated with Four Azoles
Hornby, J. M., & Nickerson, K. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2305-2307.2004 · Cited by 137
Kurtz, M. B., Abruzzo, G., Flattery, A., Bartizal, K., Marrinan, J. A., Li, W., Milligan, J., Nollstadt, K., & Douglas, C. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3244-3251.1996 · Cited by 136
Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence
Gravelat, F. N., Ejzykowicz, D. E., Chiang, L. Y., Chabot, J. C., Urb, M., Macdonald, K. D., al-Bader, N., Filler, S. G., & Sheppard, D. C. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01408.x · Cited by 136
Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136 · cited 1×
“glabrata bloodstream isolates that showed elevated echinocandin MICs were examined for mutations in the drug targets FKS1 and FKS2, and all of these isolates contained mutations in previously identified hot-spot regions, implicating frequent drug target alterations in clinical echinocandin resistance (657).”
BackgroundSheppard, D. C., Doedt, T., Chiang, L. Y., Kim, H. S., Chen, D., Nierman, W. C., & Filler, S. G. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0617 · Cited by 135
In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus
Steinbach, W. J., Schell, W. A., Blankenship, J. R., Onyewu, C., Heitman, J., & Perfect, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1664-1669.2004 · Cited by 135
Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134 · cited 2×
“None of the strains showed significant resistance to micafungin or caspofungin in liquid microdilution susceptibility assays (419).”
BackgroundSundstrom, P., Balish, E., & Allen, C. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/338836 · Cited by 134
Mattia, E., Carruba, G., Angiolella, L., & Cassone, A. (1982) · Journal of Bacteriology · doi:10.1128/jb.152.2.555-562.1982 · Cited by 133
Lamb, D. C., Kelly, D. E., White, T. C., & Kelly, S. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.63-67.2000 · Cited by 133
Kelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133 · cited 1×
“Amphotericin B-resistant isolates from an AIDS patient were found to have defective 8-7 isomerase activity (274).”
BackgroundBhabhra, R., Miley, M. D., Mylonakis, E., Boettner, D., Fortwendel, J., Panepinto, J. C., Postow, M., Rhodes, J. C., & Askew, D. S. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4731-4740.2004 · Cited by 133
Desnos-Ollivier, M., Bretagne, S., Raoux, D., Hoinard, D., Dromer, F., & Dannaoui, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00088-08 · Cited by 132
Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis
Lopes da Rosa, J., Boyartchuk, V. L., Zhu, L. J., & Kaufman, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912427107 · Cited by 132 · cited 2×
“sion of the rtt109 homozygous deletion mutant (344) as well as”
BackgroundKo, Y.-J., Yu, Y. M., Kim, G.-B., Lee, G.-W., Maeng, P. J., Kim, S., Floyd, A., Heitman, J., & Bahn, Y.-S. (2009) · Eukaryotic Cell · doi:10.1128/ec.00120-09 · Cited by 132
Wiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5146-5148.2005 · Cited by 131
The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?
Mowat, E., Williams, C., Jones, B., Mcchlery, S., & Ramage, G. (2009) · Medical Mycology · doi:10.1080/13693780802238834 · Cited by 131 · cited 1×
“fumigatus biofilm-like structures have been observed for some time, as cultures grown under aerial static conditions show different structures of mycelial networks from those grown under submerged liquid conditions (46, 395, 396).”
BackgroundMulhern, S. M., Logue, M. E., & Butler, G. (2006) · Eukaryotic Cell · doi:10.1128/ec.00155-06 · Cited by 130
Yue, C., Cavallo, L. M., Alspaugh, J. A., Wang, P., Cox, G. M., Perfect, J. R., & Heitman, J. (1999) · Genetics · doi:10.1093/genetics/153.4.1601 · Cited by 130
MULLBACHER, A., WARING, P., & EICHNER, R. D. (1985) · Microbiology · doi:10.1099/00221287-131-5-1251 · Cited by 130
Feldmesser, M., Kress, Y., Mednick, A., & Casadevall, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/317614 · Cited by 130
Argimón, S., Wishart, J. A., Leng, R., Macaskill, S., Mavor, A., Alexandris, T., Nicholls, S., Knight, A. W., Enjalbert, B., Walmsley, R., et al. (2007) · Eukaryotic Cell · doi:10.1128/ec.00340-06 · Cited by 128
Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents
d'Enfert, C. (2006) · Current Drug Targets · doi:10.2174/138945006776359458 · Cited by 128
Candida albicans Tup1 Is Involved in Farnesol-Mediated Inhibition of Filamentous-Growth Induction
Kebaara, B. W., Langford, M. L., Navarathna, D. H. M. L. P., Dumitru, R., Nickerson, K. W., & Atkin, A. L. (2008) · Eukaryotic Cell · doi:10.1128/ec.00357-07 · Cited by 126
Kojima, K., Bahn, Y.-S., & Heitman, J. (2006) · Microbiology · doi:10.1099/mic.0.28571-0 · Cited by 125
Miwa, T., Takagi, Y., Shinozaki, M., Yun, C.-W., Schell, W. A., Perfect, J. R., Kumagai, H., & Tamaki, H. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.4.919-931.2004 · Cited by 125
Twumasi-Boateng, K., Yu, Y., Chen, D., Gravelat, F. N., Nierman, W. C., & Sheppard, D. C. (2009) · Eukaryotic Cell · doi:10.1128/ec.00265-08 · Cited by 125
Franzot, S. P., & Casadevall, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.331 · Cited by 124
Hnisz, D., Majer, O., Frohner, I. E., Komnenovic, V., & Kuchler, K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000889 · Cited by 124 · cited 7×
“Cdc28 is also involved in morphogenesis, as the depletion of Cdc28 leads to filamentous growth and the expression of hypha-specific transcripts, such as HWP1 and ECE1 (590).”
BackgroundInfluentialShi, Q.-M., Wang, Y.-M., Zheng, X.-D., Teck Ho Lee, R., & Wang, Y. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0442 · Cited by 124
Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin.
Imai, J., & Yahara, I. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9262-9270.2000 · Cited by 123 · cited 1×
“albicans; Hsp90 interacts with the catalytic subunit of calcineurin and is critical for maintaining its stability (247, 536).”
BackgroundGenome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon
Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhäuser, J., Nantel, A., Raymond, M., & Rogers, P. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00327-07 · Cited by 123
Maidan, M. M., Thevelein, J. M., & Van Dijck, P. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330291 · Cited by 123
Markovich, S., Yekutiel, A., Shalit, I., Shadkchan, Y., & Osherov, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3871-3876.2004 · Cited by 122 · cited 1×
“Furthermore, the terminal MAPK in the cascade, Slt2, is activated by phosphorylation after exposure to echinocandins (484), and cells lacking SLT2, BCK1, and PKC1 are hypersensitive to echinocandins, demonstrating that the PKC pathway is required for echinocandin tolerance (366, 484).”
BackgroundPhosphorylation of Rga2, a Cdc42 GAP, by CDK/Hgc1 is crucial for Candida albicans hyphal growth
Zheng, X., Lee, R. T. H., Wang, Y.-M., Lin, Q., & Wang, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601814 · Cited by 121
Onyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121
Bassilana, M., Blyth, J., & Arkowitz, R. A. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.1.9-18.2003 · Cited by 120
Bahn, Y.-S., Hicks, J. K., Giles, S. S., Cox, G. M., & Heitman, J. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1476-1491.2004 · Cited by 120
Stress-Induced Phenotypic Switching in Candida albicans
Alby, K., & Bennett, R. J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0040 · Cited by 119
Wang, P., Nichols, C. B., Lengeler, K. B., Cardenas, M. E., Cox, G. M., Perfect, J. R., & Heitman, J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.2.257-272.2002 · Cited by 119
Davidson, R. C., Nichols, C. B., Cox, G. M., Perfect, J. R., & Heitman, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03563.x · Cited by 119
Wang, P., Cardenas, M. E., Cox, G. M., Perfect, J. R., & Heitman, J. (2001) · EMBO reports · doi:10.1093/embo-reports/kve109 · Cited by 117
Melo, A. S., Colombo, A. L., & Arthington-Skaggs, B. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00676-07 · Cited by 117
Bachmann, S. P., Patterson, T. F., & López-Ribot, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2228-2230.2002 · Cited by 117
Paugam, A., Dupouy-Camet, J., Blanche, P., Gangneux, J. P., Tourte-Schaefer, C., & Sicard, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975-a · Cited by 117
Sugui, J. A., Kim, H. S., Zarember, K. A., Chang, Y. C., Gallin, J. I., Nierman, W. C., & Kwon-Chung, K. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002655 · Cited by 117
Xue, T., Nguyen, C. K., Romans, A., & May, G. S. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.557-560.2004 · Cited by 117
Wickes, B. L., Edman, U., & Edman, J. C. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.6322001.x · Cited by 116
Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., & Fadda, G. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1352-1359.2006 · Cited by 116
Kontoyiannis, D. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg090 · Cited by 116
Research works printed but not linked: 6
- Clinical Laboratory Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Approved standard M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
- 10.1111/j.1574-6968.2001.tb10853.x · doi:10.1111/j.1574-6968.2001.tb10853.x · Paper page
- 10.1128/am.25.2.309-312.1973 · doi:10.1128/am.25.2.309-312.1973 · Paper page
- 10.1091/mbc.e03-11-0782 · DOI · Paper page
- Kwon-ChungK. J. BennettJ. E.. 1992. Medical Mycology. Lea & Febiger, Philadelphia, PA.
- PrasadT.. 2010. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res. 10:587–596.
Cited by
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Elevated chitin content following echinocandin exposure is also observed in C. tropicalis, C. parapsilosis, and Candida guillermondii, in addition Cell wall stress Target alteration or overexpression Up-regulation of multidrug transporters Cellular stress responses - Mediators of stress-response pathways include: Hsp9…”
BackgroundInfluentialSelf-citationAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“fumigatus, and that it is observed in an invertebrate model of candidiasis (Cowen et al. 2009; Singh et al. 2009; Shapiro et al. 2011).”
BackgroundCandida albicans cell-type switching and functional plasticity in the mammalian host
Noble, S. M., Gianetti, B. A., & Witchley, J. N. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.157 · Cited by 521
Metadata
- Authors
- Shapiro, R. S., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-06
- Volume
- 75
- Issue
- 2
- Pages
- 213-267
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- PMC
- PMC3122626
- OpenAlex
- W2114409750
- Cited by
- 576
- References
- 662
- Citations by year
- 2026: 21 · 2025: 35 · 2024: 34 · 2023: 33 · 2022: 33 · 2021: 44 · 2020: 51 · 2019: 51 · 2018: 46 · 2017: 51 · 2016: 27 · 2015: 43 · 2014: 35 · 2013: 34 · 2012: 32
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology and Molecular Biology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-86452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- fungal pathogens, signal transduction, fungal morphogenesis, drug resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, yeast-to-hypha transition, drug target alterations, cellular stress response, fungal virulence, opportunistic fungal infection, conserved signaling pathways
- MeSH terms
- Antifungal Agents, Fungi, Humans, Mycoses, Signal Transduction, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.